Survival Benefit of Adjuvant Chemotherapy After Pancreatoduodenectomy for Ampullary Adenocarcinoma: a Propensity-Matched National Cancer Database (NCDB) Analysis.

Sivesh Kathir KamarajahFilip BednarClifford S ChoHari Nathan

Published in: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract (2020)

In this large retrospective cohort study, AC after resected ampullary adenocarcinoma was associated with a survival benefit in patients, including patients with node-negative and margin-negative disease.

Keyphrases

end stage renal disease
squamous cell carcinoma
prognostic factors
lymph node
newly diagnosed
ejection fraction
chronic kidney disease
locally advanced
free survival
emergency department
radiation therapy
adverse drug
patient reported